The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the first-ever results from the Phase 1b RedirecTT-1 study of TECVAYLI® (teclistamab-cqyv), a first-in-class BCMAxCD3...

– PRGN-2009 combined with an investigational checkpoint inhibitor resulted in a 30% ORR in patients with heavily pre-treated HPV-associated cancers that were naïve or resistant to checkpoint...

-- Breadth of pipeline featured in multiple early clinical data presentations, reflecting diversity of fundamental growth drivers across development programs -- CAMBRIDGE, Mass., June 3, 2023...

Initial data showed promising signs of efficacy, including a 47.1% ORR in patients with resistant/refractory gastric cancer expressing Claudin 18.2, with a well-tolerated safety profile Elevation...

Compared To Synthetic Controls, INT230-6 Alone Extended Survival In Refractory Soft Tissue Sarcoma Subjects by Nearly 450 Days With Favorable Safety INT230-6, a Locally Delivered Cytotoxic...

-- Patricia Mae Garcia Santos, MD, MS, receives annual Conquer Cancer-Women Leaders in Oncology "Women Who Conquer Cancer" Young Investigator Award -- -- Tafadzwa L. Chaunzwa, MD, MHS, receives...

The Howard Hughes Corporation® (NYSE: HHC) announced today that Chief Executive Officer David O'Reilly will participate in a presentation moderated by Anthony Paolone from JP Morgan at NAREIT's...

"Between Two Worlds" Awarded Grand Prize at Gala Event, 2023 Auggie Award Winners Also Announced SANTA CLARA, Calif., June 2, 2023 /PRNewswire/ -- Augmented World Expo (AWE), the leading series of...

Promontory Therapeutics Inc., a clinical stage pharmaceutical company advancing small molecule immunotherapies in oncology, announces preliminary data from a Phase 2 clinical trial of the...

As the London Blockchain Conference draws to a close, attendees heard from industry experts on Driving Innovation with Blockchain. LONDON, June 2, 2023 /PRNewswire/ -- As the London Blockchain...

After 7 years, the annual National Strip-Tillage Conference is returning to Bloomington-Normal, Ill., for its 10th-anniversary gathering. The event is hosted by Strip-Till Farmer, one of several...

Cure CEO Seema Kumar to Announce BioGENEius Award Winner at BIO Opening Plenary and participate in Women In Bio Plenary June 5 Cure to Showcase Cure Innovation Labs, CureXChange Collaboration...

In addition to the uMR® Jupiter 5T, the 12-year old company will exhibit its uAIFi artificial intelligence technology platform and translational medical research systems, and present an open MR...

Markor International Home Furnishings ("Markor") (SHE:600337), a leading Chinese producer of home furnishings, is currently participating in the 10th China Furniture Industry Expo (Ganzhou). As...

V2X, Inc., (NYSE: VVX), a leading provider of critical mission solutions and support to defense clients globally, announced that company management will address the Stifel 2023 Cross Sector...

Get ready for an unforgettable grand finale as an exciting line-up featuring Houman Haddad from the World Food Program will deliver a ground-breaking talk on Transforming Humanitarian Cooperation...

CSI Compressco LP ("CSI Compressco") (NASDAQ: CCLP) announced today that it will be presenting at the 13th Annual LD Micro Invitational Conference and the Bank of America Securities Energy Credit...

ZB131 is a first-in-class humanized monoclonal antibody targeting cancer-specific plectin (CSP), which is expressed on the surface of cancer cells in solid tumors Interim data demonstrates safety...

──New Patient Data Further Implicates CCL24 in Fibrotic Disease Pathology and Prognosis and Supports Rationale for the Role of Chemomab's CCL24-Neutralizing Antibody CM-101 in Systemic...

New program empowers developers at non-profit organizations to quickly build web and mobile applications without the high barriers of cost or managing search infrastructure. EL SEGUNDO, Calif.,...

Keynote address unveils the future of cooking with AR glasses World renowned Chef Ming Tsai demonstrates NEW YORK, June 2, 2023 /PRNewswire/ -- Kittch, the leading innovator in culinary...

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive...

Next-gen cybersecurity tool looks to revolutionize information security by leveraging the BSV blockchain LONDON, June 2, 2023 /PRNewswire/ -- Yesterday, at the London Blockchain Conference,...

The 6th (Cangzhou) Garden Exposition of Hebei Province kicked off on May 26 in Cangzhou, China's northern city that thrives on canal. A total 19 activities in five categories, including academic...

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conferences: Jefferies Healthcare Conference Wednesday, June 7 at 12:30 p.m. EDT